ABSTRACT
INTRODUCTION
The recent development of inexpensive high-throughput gene sequencing and microarray technologies has accelerated the accumulation of knowledge about genes and their protein products. To manage and analyze this basic data, researchers rely on experiment-specific databases (Bairoch and Boeckmann, 1991; Wheeler et al., 2003 ). However, higher-level conceptual knowledge about genes, such as function, is still primarily disseminated as written natural language in journal articles and the comment fields of database records. Developing natural language methods for extracting and storing this knowledge would make it accessible for computational analysis.
Some groups are developing algorithms to analyze text and automatically construct databases of protein-protein interactions (Blaschke et al., 1999; Ng and Wong, 1999; Thomas et al., 2000; Jenssen et al., 2001; Ono et al., 2001; Park et al., 2001; Wong, 2001; Yakushiji et al., 2001) , protein cellular localization (Craven and Kumlien, 1999) , metabolic * To whom correspondence should be addressed.
enzymes (Humphreys et al., 2000) , gene-drug interactions (Craven and Kumlien, 1999; Rindflesch et al., 2000) , gene and gene products (Sekimizu et al., 1998) , diseases associated with proteins or keywords (Andrade and Bork, 2000; Craven and Kumlien, 1999) , and other relationships (Hirschman et al., 2002) . Other algorithms may even create new knowledge by combining information from disparate communities (Smalheiser and Swanson, 1998; Blagosklonny and Pardee, 2002) . For biology, building these databases require methods to identify the names of entities, such as genes and proteins, accurately. Errors in this step can lead to problems in downstream algorithms; overlooked gene names accounted for 85% of the missed interactions in the protein-protein interaction database PubGene (Jenssen et al., 2001) .
Unfortunately, computationally finding gene and protein names in natural language text is diffcult. The lack of uniform nomenclature standards has resulted in discordant naming practices (Jan, 1997; White et al., 2002 , http://www. nature.com/ng/web_specials/nomen/nomen_article.html). To handle the resulting diversity of the names, gene and protein name identification algorithms use combinations of approaches including: Dictionary, searching from a list of known gene names; Appearance, deducing word type based on its makeup of characters; Syntax, filtering words based on parts of speech; Context, using nearby words to infer gene and protein names; and Abbreviation, using abbreviations in text to help identify names (Table 1) .
Perhaps the simplest approach is to create a dictionary of all known gene and protein names. Krauthammer invented such a method by adapting BLAST to search a database of gene names, rather than DNA sequences (Krauthammer et al., 2000; Altschul et al., 1990) . Because BLAST allowed approximate matches, this method could also detect small variations of the gene names in the dictionary. Although such dictionary-based methods are easy to understand and relatively simple to implement, maintaining dictionaries is difficult given the rapid rate of genome research. The Mouse Genome Database (http://www.informatics.jax.org/ mgihome/nomen/short_gene.shtml) alone logged 166 name Narayanaswamy et al. (2003).] additions and withdrawals in a single week (Mouse Genome Database, 2002; Friedman et al., 2003) . One insight that decreased the reliance on dictionaries is that, despite their diversity, many gene names 'look like' other gene names. The appearance of a word, its suffixes, prefixes, capitalization or numbers, can help identify it as a gene or protein (Fukuda et al., 1998) . One particularly strong clue that a word may be a protein is the suffix '-ase', which the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC_IUBMB) has standardized for naming enzymes (Webb, 1992) . Another commonly used heuristic is the '-in' suffix. However, although many protein names end with '-in', that suffix is also common among technical words, such as penicillin, heparin or serotonin (Table 2) . Appearance clues can mislead when scientific naming conventions, such as those for cell lines or viruses, are similar to those of genes (Tanabe and Wilbur, 2002b) .
Fortunately, leveraging the syntax of a sentence can alleviate some errors. Since all names are nouns, a part of speech tagger can restrict the domain of words and eliminate the possibility of erroneously identifying words that have other parts of speech.
Another use of syntax structure is to define the local context of a putative gene or protein name. A noun phrase with a gene or protein name often contains related words, such as those that describe molecular function or interactions. One system EDGAR contains a contextual identification module that uses the signal words directly before gene names, such as activated, expression, mutated or gene (Rindflesch et al., 2000) . Other systems consider more distant words (Fukuda et al., 1998; Narayanaswamy et al., 2003) . However, such heuristics miss the many occurrences of gene names without context clues (Tanabe and Wilbur, 2002a) .
One final characteristic of gene names that has not yet been fully exploited is morphology, the derivation and formation of words. Biologists sometimes indicate relationships among genes and proteins by varying their prefixes or suffixes. For example, the cdk4 and cdk7 genes share the stem 'cdk' and are both involved in cell cycle regulation. Since biologists name many genes similarly, examining the variants of a word stem can help classify it as a gene or protein name. Morphology is analogous to appearance because they both scrutinize the patterns of characters in a word. However, while the appearance of a word can be examined by itself, our notion of morphology compares the appearance of a word to the other words in the lexicon.
To handle the diversity of gene and protein names, we have implemented a method called GAPSCORE that combines syntax, appearance, context and morphology. Our notion of context, however, differs from that of previous approaches. To identify a single word gene name that occurs without context clues, we use all information about the word in MEDLINE. We combine these characteristics using supervised machine learning.
In our supervised machine learning framework, a classifier 'learns' a model by fitting parameters based on information from a training set of labeled genes and non-genes. We quantify the appearance, morphology and context of each gene or non-gene as a numerical feature vector. Then, the classifier can identify new words by scoring it based on similarities to the previously observed training set. There are many well-studied machine learning classifiers that learn different models. Since no classifier performs best over all types of data, we tested a simple classifier, Naïve Bayes (NB), against two more complex classifiers known for high accuracy, Maximum Entropy (ME) and Support Vector Machines (SVMs) (Manning and Schütze, 1999; Burges, 1998; Ratnaparkhi, 1998) .
After developing our system, we evaluated its performance on the publicly available Yapex text collection (Franzén et al., 2002) . The Yapex collection consists of a training set of 99 abstracts from MEDLINE related to protein binding, and a test set of 101 abstracts, of which 48 are relevant to protein binding, and the rest were chosen randomly from the GENIA corpus (Ohta et al., 2002) .
Evaluating gene and protein name identification algorithms, however, is difficult. Problems stem from equivocal distinctions between genes (both genomic and transcribed mRNA) and proteins and disagreements in the definition of protein.
When reading the same text, experts agree on whether a name refers to a gene, protein or mRNA only 77% of the time (Hatzivassiloglou et al., 2001) . Furthermore, experts only agree on whether a word is even a gene or protein 69% of the time (Krauthammer et al., 2000) . The Yapex text collection addresses this ambiguity by specifically excluding peptides and protein families (Franzén et al., 2002) .
Because these ambiguities have not been explicitly resolved, algorithms often contain differing notions of protein names, which hinders direct comparison. In addition, implicit assumptions about the text also impede attempts to compare. Algorithms often perform worse when applied to a different corpus. Proux found that the precision of his method dropped from 91 to 70% when transferred from a corpus of sentences from FlyBase to a more general set of MEDLINE articles (Proux et al., 1998) . Tanabe addressed this problem by applying a Bayesian statistical method to filter articles that were not likely to contain a gene name (Tanabe and Wilbur, 2002a) .
Therefore, to obtain an accurate measure of performance, we developed the features used by our machine learning classifier on a corpus we created independent from Yapex. We also fit the parameters of the classifier on this data set. To reconcile differences in definitions of protein names, we used the Yapex training set to create a list of stop words that did not match the stricter definition of protein name in Yapex. Finally, we evaluated our algorithm on the Yapex test.
We have made our algorithm accessible from the web at http://bionlp.stanford.edu/gapscore/
METHODS
GAPSCORE scores gene and protein names in written natural language text. Since it does not distinguish between genes and proteins, we use 'gene' generically to mean both. The algorithm consists of five steps: (1) TOKENIZE: we split the document into sentences and words; (2) FILTER: we remove from consideration any word that is clearly not a gene name; (3) SCORE: we score words using a machine learning classifier; (4) EXTEND: we extend each word to the full gene name; and (5) MATCH ABBREVIATION: finally, we score abbreviations of the gene names identified (Fig. 1 ).
TOKENIZE
The TOKENIZE step identifies the sentences and words in a document. We identify the sentence boundaries using a simple set of heuristics. We start by assuming that any period, question mark or exclamation point followed by a space and then a capitalized letter is a sentence boundary. Periods that occur as part of 'e.g.' are exceptions to this rule.
Within each sentence, we define a word as a string of alphanumeric characters. Any space and most punctuation are word boundaries. We handle dashes separately since many gene names contain them (e.g. c-jun, IL-2, IGF-I). Dashes are not boundaries when the previous token is a single letter, or the next token is a number or roman numeral.
FILTER
The FILTER step removes known non-gene words to increase the overall accuracy and performance of the algorithm. We discard words that are not gene names, but may be part of a gene name. For example, the '1' and 'alpha' in 'Interleukin-1 alpha' are discarded, but recovered later in the EXTEND step.
First, we apply Brill's tagger and remove from consideration words that are not nouns, adjectives, participles, proper nouns or foreign words (Brill, 1994) . We use the default settings for the tagger, not customized for our corpus. We discard numbers, roman numerals (I-X), greek letters, amino acids, seven virus names and 13 chemical compounds. Because virus names and chemical compounds resemble gene symbols and may indicate genes in certain contexts, we conservatively discard only the ones prevalent in our training set. Finally, we discard names of organisms found in the SWISS-PROT database (Bairoch and Boeckmann, 1991) .
Finally, we discard words from a manually created list of 49 regular expression patterns. We compiled this list by running the algorithm on the Yapex training set and scanning the results for high-scoring technical terms. These patterns include seven that match words that indicate genes and proteins (e.g. protein, DNA, gene); 17 subunits, parts, or Fig. 1 . System architecture. We scan through text one word at a time, filtering words that we immediately recognize not to be gene names. Then, we score the remaining words with a machine learning classifier, extend multi-word gene names and score their abbreviations.
complexes of genes and proteins (e.g. peptide, chain, motif, complex); five related molecules (e.g. ATP, cAMP); and 20 types or descriptions of genes (e.g. receptor, expressed).
SCORE
Our algorithm scores most remaining unfiltered words using a machine learning classifier. We score separately two classes of proteins that are common and easy to recognize unambiguously: enzyme names and cytochrome P450 proteins. Gene names in these two classes automatically receive the highest possible score.
To distinguish gene names that end with '-ase', we compiled a dictionary of all known non-gene words that also end with '-ase' (e.g. kilobase, disease). We selected the 327 words that end with '-ase' or '-ases' from Webster's Second International dictionary. Then, we manually removed gene names from the list and added one word 'gases'. This resulted in a list of 196 words that are not gene names. There were no ambiguous words that had both an enzyme and a non-enzyme definition.
We also score separately the cytochrome P450 proteins because they follow a regular nomenclature (Cytochrome P450 Homepage, 2003, http://drnelson.utmem.edu/ CytochromeP450.html). We use four regular expression patterns to recognize names with the form: 'cytochrome P450 2D6', 'p450 IID6', 'CYP2d6' or just 'CYPs'. Once a regular expression matches a cytochrome P450 protein name, the algorithm also identifies in the document other short forms of the same family, e.g. '2D6', as proteins.
Most words, however, do not match these two special cases. For these, we encode their appearance, morphology, and context as a feature vector for a machine learning classifier.
Appearance
We model the appearance of two types of genes, gene symbols (such as TPMT or NAT1) and gene names that end with '-in' (e.g. insulin). For gene symbols, we compute a feature vector from the features described in Table 3 . The value of each feature is 1 if the symbol has the characteristic and 0 otherwise.
We recognize gene names that end with '-in' based on the hypothesis that those names have characteristic patterns of letters that distinguish them from other words. To find those patterns, we use a generic statistical model that learns variable length N-grams to classify phrases, described in Smarr and Manning (2002) .
To train the N-gram model, we created a training set of words that end with '-in' from Medical Subject Headings (MeSH) (Humphreys et al., 1999) . MeSH is a hierarchy of 21 973 phrases used to index MEDLINE citations. We normalized each phrase by removing numbers, single letters and roman numerals. Then, we discarded multi-word phrases, leaving only single words. We stemmed each word by removing the terminal '-s' if the resulting stem occurs as a word in MEDLINE. Finally, we removed any word that did not end with '-in', leaving a list of 708 unique words. A word was a protein if it belonged to one of 15 MeSH classes: 'Cytochromes', 'DNA Restriction-Modification Enzymes', 'Holoenzymes', 'Isoenzymes', 'Isomerases', 'Ligases', These features encode a 13 dimension vector that describes the appearance of a word. For a specific word, the value for each feature is 1 if it describes the word and 0 otherwise.
'Lyases', 'Neuropeptides', 'Oxidoreductases', 'Peptide Hormones', 'Peptides', 'Proteins', 'Receptors, Immunologic' and 'Transferases'. The remaining words were not proteins. We trained the N-gram classifier on the MeSH training set. For words that do not end with '-in', we automatically assign them the lowest possible score of 0. For words that do end with '-in,' we use the score from the classifier; those scores constitute the final dimension of the appearance feature vector.
Morphology
We model morphology by quantifying the tendency for a word to vary in ways similar to gene names. The morphology feature vector consists of scores for eight types of variations (Table 4) . We calculate the score based on the number of times a 'stem' and its 'variants' appear in MEDLINE. The stem is the word without the prefixes and suffixes, and the variant includes them. For example, one type of variation counts word stems with numbers appended. Many genes vary this way, such as ced with its variants ced1, ced3 and ced9.
The value of each morphology feature is:
log max 1 1000 , #Vars #Stems where #Stems is the number of times a stem appears by itself in MEDLINE, and #Vars is the total number of times the stem appears with a variation. Empirically, the ratio of these counts, when plotted for all words in MEDLINE, follows an exponental distribution. Therefore, to improve discrimination in machine learning, we take the log of that ratio. The final piece of the equation handles typographical and spelling errors that become significant over all of MEDLINE. For example, 'with1' occurs nine times. To alleviate the effects of such errors, we set a minimum cutoff to ignore variants that appear less than 1 time in 1000. We found this cutoff empirically based on cross-validation on our training set. We did not set a maximum ratio cutoff for variants that outnumber stems. Finally, we did not score a variant if the stem never appears in MEDLINE.
As an example, the ced word contains many variations that match the pattern 'stem + Number'. The stem ced occurs 182 times in MEDLINE, and the variants, ced1, ced3 and ced9, occur 1, 3 and 5 times. The score for ced and its three variants is thus log(9/182) = −1.31. On the other hand, with appears 5 193 871 times and all its variants (including with1) occur 82 times. Since the ratio is less than our minimum cutoff, the score for those words is −3.
We precompute the morphology score for every word in MEDLINE. For each type of variation, we first calculate the score assuming that the word is a stem. We look for all other words in MEDLINE that match that variation. For example, for the variation requiring greek letter suffixes, we look for words in MEDLINE that are composed of the stem word followed by any greek letter. For the roman numeral variation, we only consider the first 10 roman numerals since they are the most common. If a word can be either a variation or a stem, we use the higher of the two scores.
Context
Finally, we model context features based on the observation that gene names often occur next to strong positive and negative 'signal' words. For example, the word directly before 'gene' is frequently a gene name, but the word directly after 'within' is rarely one. Thus, our approach is similar to earlier systems that only consider immediate neighbors. It differs by using negative signal words as well as positive. We searched for both types of signal words by calculating the correlation between each word in MEDLINE with the presence of gene names directly before or after the word. Then, for an unknown word, the distribution of its occurrences around signal words comprises its context feature vector. Gene names should appear most often next to positive signals and least next to negative ones.
To find the signal words, we created a training set of 1025 words, which included 574 gene names. We randomly chose 500 nouns that appeared in year 2001 MEDLINE abstracts containing the word 'gene' or 'protein'. To increase the prevalence of gene names, we added 525 more words that appeared before 'gene', 'protein' or 'mrna'. We chose these words randomly to insure that there would be no bias toward making these three words signal words.
Then, for each word in MEDLINE, we tallied the number of times it occurred next to our labeled words in a 2 × 2 contigency table:
In this example, cell (A) contains the number of genes from our training set found before 'expression' anywhere in MEDLINE, cell (B) is the number of genes never found before 'expression', cell (C) is the number of non-genes found before 'expression' and cell (D) is the number of non-genes never found before 'expression'. We similarly counted the occurrences of 'expression' after gene names.
If 'expression' is a strong signal that the previous word is a gene name, then the ratio of genes to non-genes would be higher in the first column, the 'expression' column, than the second. We calculated the significance of the difference in the ratio using a χ 2 test. Out of the 287 680 words from MEDLINE that appeared next to a word from our training set, 2567 were significant with a P ≤ 1 × 10 −7 , which is roughly a P -value cutoff of 0.05 with a Bonferroni correction for multiple tests.
Although the 2567 words we found were all statistically significant, useful signal words should be also ubiquitous. Obscure words could only discriminate a small number of names. Therefore, we further narrowed our list by selecting the most common signal words. Since only nine of the 2567 words were positive signal words, we kept them all. Then, for balance, we chose the nine negative signal words that appeared with the greatest number of words in our training set. This resulted in the 18 signal words that are listed in Table 5 .
Then, we used these signal words to encode the context of a word into feature vectors. Each feature is the number of times that a word occurs with each signal word across all of MEDLINE. We calculated the distribution across signal words by normalizing the feature vector to 1.0.
Classifier
Finally, we concatenated the appearance, morphology and context vectors to create the final combined vector.
To train the machine learning classifiers, we created a training set of words from 634 MEDLINE abstracts found from searches on regulatory elements and 101 MEDLINE abstracts cited by a review article on pharmacogenomics (Evans and Relling, 1999) . We manually categorized each word from these abstracts as either a gene name or non-gene. For a multiple word gene name, we labeled as genes only the core gene-meaning words. We labeled ambiguous words, those that have a dominant non-gene meaning, non-genes. In addition, we included 8617 words from MeSH that we identified using the criteria described above in the Morphology section. This resulted in a training set of 19 952 unique labeled words. We used these words and trained three types of classifiers: NB, ME and SVM. Since NB required categorical features, we binned the features. For each dimension in the feature vector, we assigned the values into five bins evenly spaced between the lowest and highest values. For ME, we estimated the parameters using a conjugate gradient descent method that has been found to converge quickly and accurately (Malouf, 2002) . We trained SVMs using the linear, polynomial and radial basis function kernels. We varied the C error penalty parameter and chose the parameters that performed best on the Yapex training set.
EXTEND TO NOUN PHRASE
After a word is scored, to identify multi-word gene names, we extend the name using heuristics similar to the ones described in Fukuda et al. (1998) . Using the parts of speech from Brill's tagger, we include the nouns, adjectives and participles preceding the putative gene name. Then, we lengthen the name to include the following words that are single letters, greek letters and roman numerals. Finally, we remove extraneous punctuation at the beginning or end of the name, except for open or close parenthesis characters required to complete a pair.
MATCH ABBREVIATIONS
After the algorithm establishes the full gene names, it searches for abbreviations in the document using the algorithm described in Chang et al. (2002) . If the long form of an abbreviation has a higher score, it transfers that score to the abbreviation. The algorithm likewise transfers higher scores from abbreviations back to the long forms.
Evaluation
We evaluated the performance of our algorithm against the Yapex test gold standard. To obtain an accurate result, we did not look at or run our algorithm against this data set until after we had finalized it and fitted all parameters. To compare, we ran the Yapex algorithm, available from their web site, on that data set on 4 June 2003. When the Yapex algorithm predicted overlapping gene names, we used only the longest one.
We quantified the performance of the algorithms using recall, precision and F -score. Recall # correctly predicted gene names # gene names measures how thoroughly a method can identify gene names.
Precision
# correctly predicted gene names # predictions indicates the rate an algorithm produces errors.
F -score 2 * recall * precision recall + precision combines recall and precision into a single number.
We assessed the performance of the algorithms on 'exact' and 'sloppy' gene name matches using the definitions described in Franzén et al. (2002) . Using exact match, the predicted gene name must be equivalent to the corresponding name in the gold standard. Using sloppy match, a predicted gene name only needs to overlap the name in the gold standard. However, if two predicted genes overlap the same multi-word gene name, only one is considered correct and the other is incorrect.
Since our algorithm could produce scores, we calculated the recall and precision at every score cutoff. The resultant curve illustrates the tradeoff between recall and precision. The user can choose a strict cutoff for applications that require high precision, or a more lenient one for applications that require high recall. This table shows the performance of GAPSCORE (using sloppy match scoring on the Yapex training set) with different modules disabled. The modules are sorted by increasing F -score. The first three columns shows the greatest F -score that the reduced algorithm can achieve, as well as the recall and precision at that F -score. F -score is the decrease in F -score compared to the complete algorithm. Prec/75 is the precision at 75% recall.
RESULTS
We trained NB, ME and SVM classifiers on our own training set. Since this training set consisted of words and not phrases, there was no distinction between sloppy or exact match. Thus, a gene name prediction was correct if the word was labeled a gene in the data set. Since SVMs required user-specified parameters, we tested various combinations of kernels and C error penalty parameters. [See Burges (1998) for a description of the parameters.] The F -scores of these parameters varied from 74 to 78%, attained by a linear kernel with C = 5. Using optimal parameters, we compared the performance of NB, ME and SVM on the Yapex training set, scoring with sloppy matches (Table 6 ). Although all classifiers performed comparably, the F -score for SVM was slightly higher than the rest. At its maximum F -score, SVM scored 3.5% higher precision with 2.1% loss in recall compared with ME, the next best performing classifier. However, at the same recall as ME, 81.4%, SVM only improved precision by a marginal 0.4%. Then, with the best classifier parameters, we tested the algorithm with various modules disabled (Table 7) . Leaving out the negative filter had the most detrimental impact on performance, resulting in a 11.8% decrease in F -score, while leaving out context features had the least effect, leading to a 0.5% decrease. We also tested the context feature with only the positive and only the negative signal words. Leaving Fig. 2 . Performance on Yapex. We compared the performance of GAPSCORE and Yapex on the Yapex test set using sloppy and exact match scoring. For sloppy match, a gene name prediction is correct if it partially matches the actual gene name. For exact match, the predicted name must match the whole gene name.
out the positive signal words decreased the F -score 0.07%, and leaving out the negative ones led to a larger decrease of 0.14%.
Finally, we ran GAPSCORE on the Yapex test set and compared the performance against the Yapex algorithm (Fig. 2) . On sloppy match, the Yapex algorithm received an F -score of 75.4% at recall and precision of 70.3 and 81.4%. In comparison, GAPSCORE achieved 82.5% F -score at 83.3 and 81.8%. The performance on exact match was closer, with Yapex receiving 54.3% F -score (50.1% recall, 59.3% precision) and GAPSCORE 57.6% (58.5% recall, 56.7% precision).
The performance of Yapex and GAPSCORE differed with respect to the length of the gene name. The Yapex test set contains 1967 gene names; 1546 of those names consist of only a single word. On sloppy match, GAPSCORE found 85% of the one word names but only 76% of the multi-word ones. Yapex exhibited a smaller discrepancy in performance and found 71% of the one word names and 67% of the others.
DISCUSSION
We have created a method GAPSCORE that identifies protein and gene names from text. It uses a word-based approach and scores the confidence that a word may be a gene based on appearance, morphology and context criteria that includes information from all of MEDLINE. To identify the boundaries of multi-word gene names, GAPSCORE extends the name using heuristics on part of speech tags. GAPSCORE scores new words using an SVM. With careful parameter tuning, this algorithm outperformed ME and NB. The performance of the linear kernel exceeded that of the more complex ones including radial basis function. However, the differences among the various parameters and classifiers were largely insubstantial.
In contrast, leaving out different modules led to more dramatic impacts on performance. Disabling the filter reduced F -score by 20%, because many un-specific gene terms scored highly. The word 'protein' occurred 199 times. Fortunately, the manually constructed filter successfully discarded those terms in the complete system. The next largest reduction in performance came from removing appearance features, which confirms the approaches of some earlier methods. However, even without appearance, the classifier could still achieve an F -score of 70.2%, suggesting that the other features contain much information about genes.
When comparing performance loss between the two types of signal words in the context features, it is counterintuitive that removing the negative signal words had a greater impact than removing the positive. After all, positive signal words have been commonly used as gene name markers, while negative signal words have not been used conversely. This performance can be explained by the greater prevalence of the negative signal words. They are much more common than the positive signal words, and thus affect a greater number of words overall. Nevertheless, the performance difference is small.
Using all features, GAPSCORE outperformed Yapex by an F -score of 7.1% on sloppy match and 3.3% on exact match. In addition, GAPSCORE found a relatively larger portion of single word genes than Yapex. These differences in performance indicate (1) more sophisticated analysis of single words can help overall accuracy and (2) deeper syntactic analysis can help find the correct boundaries for the names.
Nevertheless, methods that analyze single words will never be able to identify some phrases that indicate genes. For example, 'parathyroid hormone' is a peptide hormone encoded by a gene. However, neither 'parathyroid' nor 'hormone' would indicate a gene by itself. Identifying these phrases would require scoring phrases or collocations rather than single words.
Fortunately, such phrases that signify genes were not a significant source of error. More substantial errors for GAPSCORE arose from differences in notions of gene. The 10 highest scoring false positives were 'Kunitz-type protease', 'PTK', 'alpha2', 'beta-globin', 'branched-chain alphaketoacid dehydrogenase', 'conditional tyrosine kinase', 'elevated tyrosine kinase', 'endogenous 5-lipoxygenase', 'globin' and 'glycoprotein'. These proteins and genes may be missing from Yapex because its definition excludes protein families. GAPSCORE was more sensitive and identified many names that did not indicate a single identifiable gene. When evaluating the names found by decreasing score, the first name that was not a gene was 'COS-1', the 550th name at recall and precision of 25 and 90%. Thus, these results underscore the importance of developing clear definitions of protein names.
Some of the names from the list of false positives, and the relative decrease in performance on exact match, suggest that deeper analysis is required to correctly identify name boundaries. For example 'conditional tyrosine kinase' should not include the word 'conditional'. In the future, we will investigate more sophisticated methods for finding boundaries than part of speech heuristics. One possible approach is to use markov models that quantify the tendencies of certain words to appear together (Majoros et al., 2003) .
We also have not yet directly addressed ambiguous namesthose that mean genes in some contexts and non-genes in others. Our current strategy of labeling those words in our training set as non-genes add noise to our data and could have hurt our performance. These may need to be handled separately. In addition, the context could be used to update the confidence of ambiguous gene name predictions.
Finally, several difficult problems remain in gene name identification. There is still considerable ambiguity in the definition of the task; related entities must be differentiated, for example gene and gene products, gene structure, gene families, protein domains, protein complexes and alleles. Also confounding the task is the inconsistent naming of many genes. These differences may be small variations in tokenization or word order, or the names may be unrelated synonyms (Yu et al., 2002; Hanisch et al., 2003) . Therefore, methods must be developed to normalize synonyms and other variants before these algorithms are generally useful for unambiguous indexing and extraction tasks.
Nevertheless, we have begun using our algorithm on a relationship extraction project. Preliminary timings indicate that our current implementation, running on a (busy) single processor 1.5 GHz Intel Xeon with 512 Mb of RAM, requires an average of 15 s to tag each MEDLINE abstract. Another technical limitation to such a data-intensive approach is that the method may need retraining as new words and word senses are introduced into the literature. It is unclear how rapidly the literature is changing, and how sensitive the algorithm is to these changes.
In conclusion, we have developed a new method, GAPSCORE, for finding gene and protein names by combining novel formulations of features in a machine learning framework. We found that SVMs slightly outperform other popular methods. When applied to the Yapex text collection, our method achieves high performance due to its sophisticated analysis of single words and the high prevalence of single word gene names. The algorithm produces confidence scores that can be adjusted for either high recall or precision. We have made GAPSCORE available on the web at http://bionlp.stanford.edu/gapscore/
